Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
BlackThorn Therapeutics

BlackThorn Therapeutics

A biopharmaceutical company developing neurobehavioural therapeutic treatments using artificial intelligence and clinical neuroscience.

All edits by  Alexander Leirvåg 

Edits on 29 Jun, 2020
Alexander Leirvåg
Alexander Leirvåg approved a suggestion from Golden's AI on 29 Jun, 2020
Edits made to:
Article (+30/-30 characters)

On October 20, 2016 BlackThorn Therapeutics announced raising $40 million in series A funding from ARCH Venture Partners (lead investor), Mercury Fund, Johnson & Johnson Innovation, Altitude Life Science VenturesAltitude Life Science Ventures, and Alexandria Real Estate Equities. The company plans on using their series A funding to continue developing targeted and novel treatments for neurobehavioral disorders.

Golden logo
By using this site, you agree to our Terms & Conditions.